Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Filed with BSE · · 4 pages · English
Summary by 6ix AI
Fermenta Biotech Limited has filed a disclosure regarding a substantial acquisition of shares under SEBI regulations. The filing reports that Ms. Preeti Thakkar, a promoter of the company, sold a portion of her shareholding in the open market. This disclosure is made in compliance with the regulations governing substantial acquisitions and takeovers.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
This is to inform you that Ms. Preeti Thakkar, Promoter of Fermenta Biotech Limited (“Company”), has sold a portion of her shareholding i.e. 11,65,938 (3.96%) equity shares of the Company on September 28, 2026 in the open market. Disclosure in terms of Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 made by Ms. Preeti Thakkar is enclosed herewith for yo
Earlier from Fermenta Biotech
- Fermenta Biotech Ltd Press Release Sep 29 2026
- Fermenta Biotech Ltd Press Release Sep 16 2026
- Fermenta Biotech Ltd Press Release Aug 27 2026
- Fermenta Biotech Ltd Press Release Aug 26 2026
- Fermenta Biotech Ltd Press Release Aug 17 2026
Later from Fermenta Biotech
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For Quarter And Half Year Ended September 30, 2026.
- Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended September 30, 2026.
- Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results For Quarter Ended September 30, 2026.
- Intimation Regarding The Board'S Decision To Close The Company'S Wholly-Owned Subsidiary - Fermenta Biotech (UK) Limited.
Follow Fermenta Biotech into a list and get an email when it puts out news.
Follow Fermenta Biotech